Nurse Practitioner · Redding, CA
NPI
1578974010
Since 2014
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2107 Airpark Dr
Redding, CA, 96001
Phone (530) 241-1111
Groups this clinician bills Medicare through
Medicare paid, 2024
$231K
6,234 services
Medicare patients, 2024
1,243
Average age 74
Drug cost, 2024
$2.6M
1,607 prescriptions
Company payments, 2025
$8,379
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Justin C Blumreich was code 17003 (destruction skin lesion), 2,319 times for 483 patients. In total Justin C Blumreich billed 6,234 services in 53 codes, and Medicare paid $231K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 2,319 | 483 | $4.14 | $9,608 |
| 99213 Office E&M - Established | Office | 1,150 | 772 | $50.16 | $58K |
| 17000 Destruction Skin Lesion | Office | 840 | 625 | $34.03 | $29K |
| 99214 Office E&M - Established | Office | 364 | 253 | $70.69 | $26K |
| 11102 Skin Biopsy | Office | 358 | 316 | $57.96 | $21K |
| 96910 Skin | Office | 275 | 11 | $83.65 | $23K |
| 99203 Office E&M - New | Office | 274 | 274 | $51.50 | $14K |
| 99204 Office E&M - New | Office | 75 | 75 | $89.02 | $6,677 |
| 99212 Office E&M - Established | Office | 74 | 70 | $31.90 | $2,361 |
| 11103 Skin Biopsy | Office | 65 | 49 | $32.05 | $2,083 |
| 17262 Destruction Skin Lesion | Office | 54 | 48 | $102.50 | $5,535 |
| 17282 Destruction Skin Lesion | Office | 45 | 39 | $121.60 | $5,472 |
| 17110 Destruction Skin Lesion | Office | 42 | 39 | $72.20 | $3,033 |
| 17281 Destruction Skin Lesion | Office | 38 | 34 | $98.44 | $3,741 |
| 17004 Destruction Skin Lesion | Office | 36 | 23 | $96.56 | $3,476 |
By year: 2022 $226K for 5,517 services; 2023 $238K for 6,156 services; 2024 $231K for 6,234 services.
Medicare prescription drug claims, 2024
In 2024, the drug Justin C Blumreich prescribed most often to Medicare patients was Doxycycline Hyclate, with 218 prescriptions and refills. In total Justin C Blumreich wrote 1,607 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Doxycycline Hyclate Generic | 218 | 318 | 70 | $4,828 |
| Mometasone Furoate Generic | 179 | 190 | 96 | $3,739 |
| Montelukast Sodium Generic | 143 | 213 | 46 | $700 |
| Dupixent Pen Dupilumab | 131 | 131 | 18 | $478K |
| Ketoconazole Generic | 129 | 131 | 67 | $1,783 |
| Triamcinolone Acetonide Generic | 115 | 137 | 72 | $2,056 |
| Tremfya Guselkumab | 58 | 108 | 16 | $765K |
| Mupirocin Generic | 56 | 58 | 41 | $331 |
| Dupixent Syringe Dupilumab | 41 | 41 | Under 11 | $149K |
| Minoxidil Generic | 34 | 56 | Under 11 | $363 |
| Terbinafine Hcl Generic | 34 | 56 | 21 | $235 |
| Clindamycin Phosphate Generic | 28 | 36 | 13 | $933 |
| Dutasteride Generic | 26 | 58 | Under 11 | $1,346 |
| Taltz Autoinjector Ixekizumab | 26 | 26 | Under 11 | $172K |
| Finasteride Generic | 26 | 34 | Under 11 | $247 |
Brand drugs: 374 claims; generic drugs: 1,233 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Justin C Blumreich $8,379 ($8,379 in general payments such as food, travel and fees) from 15 companies. The largest payer was Eli Lilly and Company with $3,150.
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company LLY | 2 | $3,150 |
| Galderma Laboratories, L.P. GALD.SW | 13 | $1,992 |
| Abbvie Inc. ABBV | 39 | $1,326 |
| LEO Pharma Inc. | 13 | $334 |
| Genzyme Corporation SNY | 10 | $320 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $259 |
| Janssen Biotech, Inc. JNJ | 6 | $226 |
| Incyte Corporation INCY | 4 | $202 |
| Organon LLC OGN | 2 | $187 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $178 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.